Review Article | Published:

Using space-based investigations to inform cancer research on Earth

Nature Reviews Cancer volume 13, pages 315327 (2013) | Download Citation

Abstract

Experiments conducted in the microgravity environment of space are not typically at the forefront of the mind of a cancer biologist. However, space provides physical conditions that are not achievable on Earth, as well as conditions that can be exploited to study mechanisms and pathways that control cell growth and function. Over the past four decades, studies have shown how exposure to microgravity alters biological processes that may be relevant to cancer. In this Review, we explore the influence of microgravity on cell biology, focusing on tumour cells grown in space together with work carried out using models in ground-based investigations.

Key points

  • In the microgravity environment of space, cells assemble into multicellular three-dimensional constructs.

  • Reduced gravitational force has been shown to have far-ranging effects on cell growth and function, including effects on gene expression, the production of soluble factors, cell signalling and cytoskeletal organization.

  • Suspension-based cell culture can be achieved using the rotating wall bioreactor, clinostat, random positioning machine and magnetic levitation. These models provide certain conditions that are observed during culture in microgravity, including lack of sedimentation, reduced fluid shear, optimized cellular colocation and three-dimensional growth.

  • Research approaches derived from space-based investigations may be applicable to advance our knowledge of tumour biology, as well as inform the development of new anticancer technologies and therapeutic strategies.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    in Biology in Space and Life on Earth. Effects of Spaceflight on Biological Systems (ed. Brinckmann, E.) 17–32 (Wiley-VCH, 2007).

  2. 2.

    NASA. What is Microgravity? [], (2013).

  3. 3.

    & Growing tissues in microgravity. Nature Med. 4, 901–907 (1998).

  4. 4.

    Gravity-dependent phenomena at the scale of the single cell. ASGSB Bull. 2, 95–113 (1989).

  5. 5.

    & Optimized suspension culture: the rotating-wall vessel. Am. J. Physiol. Renal Physiol. 281, F12–F25 (2001). This paper reviews the engineering principles of suspension culture and presents mechanisms for the changes in the properties of cells cultured in suspension; the operating parameters for the RWV culture system are also detailed in this review.

  6. 6.

    , , , & Tissue engineering of cartilage in space. Proc. Natl Acad. Sci. USA 94, 13885–13990 (1997).

  7. 7.

    et al. in Biomedical Results from Skylab (eds Johnson, R. S. & Dietlein, L. F.) 221–234 (Scientific and Technical Information Office, 1977).

  8. 8.

    et al. The response of single human cells to zero-gravity. In Vitro 14, 165–173 (1978).

  9. 9.

    , , & Skylab experiment results: hematology studies. Acta Astronaut. 2, 141–154 (1975).

  10. 10.

    in Biomedical Results from Skylab ( & ) 249–282 (Scientific and Technical Information Office, 1977).

  11. 11.

    Hematological and immunological changes during spaceflight. Acta Astronaut. 8, 995–1002 (1981).

  12. 12.

    Space flight and the immune system. Vaccine 11, 496–503 (1993).

  13. 13.

    & Bioreactors for tissue engineering: focus on mechanical constraints. A comparative review. Tissue Eng. 12, 2367–2383 (2006).

  14. 14.

    et al. Three-dimensional tissue culture based on magnetic cell levitation. Nature Nanotechnol. 5, 291–296 (2010). This paper presents the operating parameters for magnetic levitation cell culture.

  15. 15.

    & Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro 13, 316–328 (1977).

  16. 16.

    , , , & Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion. Proc. Natl Acad. Sci. USA 82, 1419–1423 (1985).

  17. 17.

    , , & Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl Acad. Sci. USA 89, 9064–9068 (1992).

  18. 18.

    , , & Three-dimensional culture models of normal and malignant breast epithelial cells. Nature Methods 4, 359–365 (2007).

  19. 19.

    & Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Ann. Rev. Cell Dev. Biol. 22, 287–309 (2006).

  20. 20.

    , & Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256–268 (2003).

  21. 21.

    , , , & Demonstration of an extracellular matrix in multicellular tumor spheroids. Cancer Res. 44, 3090–3097 (1984).

  22. 22.

    Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids. Cancer Res. 44, 254–258 (1984).

  23. 23.

    , , , & Influence of glucose and buffer capacity in the culture medium on growth and pH in spheroids of human thyroid carcinoma and human glioma origin. Cancer Res. 47, 3504–3508 (1987).

  24. 24.

    & A method to measure the radio and chemosensitivity of human spheroids. Adv. Exp. Med. Biol. 159, 399–417 (1983).

  25. 25.

    , , & Influence of glucose on metabolism and growth of rat glioma cells (C6) in multicellular spheroid culture. Int. J. Cancer 52, 279–285 (1992).

  26. 26.

    The use of human tumor cells grown in multicellular spheroid culture for designing and improving therapeutic strategies. J. Theor. Med. 1, 193–207 (1998).

  27. 27.

    , & Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology. Int. J. Exp. Path. 79, 1–23 (1998).

  28. 28.

    , , & Responses of gravity level variations on the NASA/JSC bioreactor system. Physiologist 35, S49–S50 (1992).

  29. 29.

    , & Cell culture for three-dimensional modeling in rotating-wall vessels: an application of simulated microgravity. J. Tiss. Cult. Meth. 14, 51–57 (1992).

  30. 30.

    , & Prospects for use of microgravity-based bioreactors to study three-dimensional host-tumor interactions in human neoplasia. J. Cell. Biochem. 51, 290–300 (1993).

  31. 31.

    , , & Reduced shear stress: a major component in the ability of mammalian tissues to form three-dimensional assemblies in simulated microgravity. J. Cell Biochem. 51, 301–311 (1993).

  32. 32.

    Clinostats and bioreactors. Grav. Space Biol. Bull. 14, 55–64 (2001). This paper presents the engineering principles and operating parameters for clinorotation.

  33. 33.

    , & Modeling tissues in 3D: the next future of pharmaco-toxicology and food research? Genes Nutr. 4, 13–22 (2009).

  34. 34.

    Some qualitative and quantitative aspects of the fast-rotating clinostat as a research tool. ASGSB Bull. 5, 23–30 (1992).

  35. 35.

    The internal dynamics of slowly rotating biological systems. ASGSB Bull. 5, 11–21 (1992).

  36. 36.

    & Characterization of primary breast carcinomas grown in three-dimensional cultures. J. Surg. Res. 142, 256–262 (2007).

  37. 37.

    et al. Human breast cancer histoid: an in vitro 3-dimensional co-culture model that mimics breast cancer tissue. J. Histochem. Cytochem. 59, 1087–1100 (2011).

  38. 38.

    et al. Heterogeneous breast tumoroids: an in vitro assay for investigating cellular heterogeneity and drug delivery. J. Biomol. Screen. 12, 13–20 (2007).

  39. 39.

    , & Three-dimensional endothelial-tumor epithelial cell interactions in human cervical cancer. In Vitro Cell. Dev. Biol. Anim. 33, 432–442 (1997).

  40. 40.

    , & Morphologic differentiation of colon carcinoma cell lines HT-29 and HT-29KM in rotating-wall vessels. In Vitro Cell. Dev. Biol. Anim. 28, 47–60 (1992).

  41. 41.

    et al. Induction of carcinoembryonic antigen expression in a three-dimensional culture system. In Vitro Cell. Dev. Biol. Anim. 33, 352–357 (1997).

  42. 42.

    et al. Microgravity culture reduces apoptosis and increases the differentiation of a human colorectal carcinoma cell line. In Vitro Cell. Dev. Biol. Anim. 36, 367–373 (2000).

  43. 43.

    & Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. Tissue Eng. Part A 15, 559–567 (2009).

  44. 44.

    et al. A three dimensional cell biology model of human hepatocellular carcinoma in vitro. Tumour Biol. 32, 469–479 (2011).

  45. 45.

    & Microgravity assay of neuroblastoma: in vitro aggregation kinetics and organoid morphology correlate with MYCN expression. In Vitro Cell. Dev. Biol. Anim. 47, 312–317 (2011).

  46. 46.

    et al. Melanoma growth and tumorigenicity in models of microgravity. Aviat. Space Environ. Med. 77, 1113–1116 (2006).

  47. 47.

    , & Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma. In Vitro Cell. Dev. Biol. Anim. 45, 523–534 (2009).

  48. 48.

    , & A novel preclinical model of human malignant melanoma utilizing bioreactor rotating-wall vessels. In Vitro Cell. Dev. Biol. Anim. 37, 121–126 (2001).

  49. 49.

    , , & Three-dimensional growth and differentiation of ovarian tumor cell line in high aspect rotating wall vessel: morphologic and embryologic considerations. J. Cell. Biochem. 51, 283–289 (1993).

  50. 50.

    , , & Three-dimensional culture of a mixed mullerian tumor of the ovary: expression of in vivo characteristics. In Vitro Cell. Dev. Biol. Anim. 33, 366–374 (1997).

  51. 51.

    , , , & Establishment of a three-dimensional human prostate organoid coculture under microgravity-simulated conditions: evaluation of androgen induced growth and PSA expression. In Vitro Cell. Dev. Biol. Anim. 33, 375–380 (1997).

  52. 52.

    et al. Three-dimensional growth of various human tumor cell lines in simulated microgravity of a NASA bioreactor. In Vitro Cell. Dev. Biol. Anim. 33, 459–466 (1997).

  53. 53.

    et al. Three-dimensional co-culture models to study prostate cancer growth, progression and metastasis to bone. Semin. Cancer Biol. 15, 353–364 (2005).

  54. 54.

    et al. Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis. Cancer Res. 68, 9996–10003 (2008).

  55. 55.

    , & Tri-dimensional prostate cell cultures in simulated microgravity and induced changes in lipid second messengers and signal transduction. J. Cell. Mol. Med. 5, 60–73 (2001).

  56. 56.

    , , & Alteration of adenylyl cyclase type 6 expression in human astrocytoma cells after exposure to simulated microgravity. J. Health Sci. 53, 534–542 (2007).

  57. 57.

    et al. Epidermal growth factor-induced cell rounding is sensitive to simulated microgravity. Aviat. Space Environ. Med. 62, 32–36 (1991).

  58. 58.

    et al. Altered gravity conditions affect early EGF-induced signal transduction in human epidermal A431 cells. ASGSB Bull. 5, 77–82 (1992).

  59. 59.

    et al. Identification of specific gravity sensitive signal transduction pathways in human A431 carcinoma cells. Adv. Space Res. 12, 145–152 (1992).

  60. 60.

    et al. Simulated conditions of microgravity increase progesterone production in I-10 Leydig tumor cell line. Int. J. Urol. 15, 245–250 (2008).

  61. 61.

    et al. Natriuretic peptide-sensitive guanylyl cyclase expression is down-regulated in human melanoma cells at simulated weightless. Acta Astronaut. 68, 652–655 (2011).

  62. 62.

    et al. Protective effects of flavonoids against oxidative stress induced by simulated microgravity in SH-SY5Y cells. Neurochem. Res. 35, 1445–1454 (2010).

  63. 63.

    , , , & MAPK and SRC-kinases control EGR-1 and NF-kappa B inductions by changes in mechanical environment in osteoblasts. Biochem. Biophys. Res. Commun. 284, 622–631 (2001).

  64. 64.

    et al. TNF-alpha-dependent activation of NF-kappa B in human osteoblastic HOS-TE85 cells is repressed in vector-averaged gravity using clinostat rotation. Biochem. Biophys. Res. Commun. 279, 2258–2264 (2000).

  65. 65.

    , , & Culture in vector-averaged gravity environment in a clinostat results in detachment of osteoblastic ROS 17/2.8 cells. Environ. Med. 43, 22–24 (1999).

  66. 66.

    et al. Effects of simulated microgravity on thyroid carcinoma cells. J. Gravit. Physiol. 9, 39–42 (2002).

  67. 67.

    et al. Simulated microgravity alters differentiation and increases apoptosis in human follicular thyroid carcinoma cells. FASEB J. 16, 604–606 (2002).

  68. 68.

    et al. Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinol. 144, 4172–4179 (2003).

  69. 69.

    et al. Long-term conditions of mickmicked weightlessness influences the cytoskeleton in thyroid cells. J. Gravit. Physiol. 11, 169–172 (2004).

  70. 70.

    et al. Simulated weightless changes the cytoskeleton and extracellular matrix proteins in papillary thyroid carcinoma cells. Cell Tissue Res. 324, 267–277 (2006).

  71. 71.

    et al. Gravity-sensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids. FASEB J. 26, 5124–5140 (2012).

  72. 72.

    & Technology and developments for the random positioning machine, RPM. Micrograv. Sci. Technol. 21, 287–292 (2007). This paper presents the engineering principles and operating parameters for the RPM.

  73. 73.

    et al. Fluid motion for microgravity simulations in a random positioning machine. Grav. Space Biol. 25, 36–39 (2011).

  74. 74.

    Desktop RPM: new small size microgravity simulator for the bioscience laboratory. [], (2000).

  75. 75.

    et al. Simulated microgravity using the random positioning machine inhibits differentiation and alters gene expression of 2T3 preosteoblasts. Am. J. Physiol. Cell Physiol. 288, C1211–C1221 (2005).

  76. 76.

    et al. Effects of simulated microgravity on proliferation and chemosensitivity in malignant glioma cells. Neurosci. Lett. 463, 54–59 (2009).

  77. 77.

    et al. Modeled gravitational unloading triggers differentiation and apoptosis in preosteoblastic cells. J. Cell. Biochem. 98, 65–80 (2006).

  78. 78.

    , & Differential behaviour of normal, transformed and Fanconi's anemia lymphoblastoid cells to modeled microgravity. J. Biomed. Sci. 17, 63–72 (2010).

  79. 79.

    et al. Molecular predictors of 3D morphogenesis by breast cancer cell lines in 3D culture. PLoS Computational Biology 6, e1000684 (2010).

  80. 80.

    , & O'Hare, M. J. Three-dimensional in vitro tissue culture models of breast cancer – a review. Breast Cancer Res. Treat. 85, 281–291 (2004).

  81. 81.

    & Capturing complex 3D tissue physiology in vitro. Nature Rev. Mol. Cell. Biol. 7, 211–224 (2006).

  82. 82.

    & Forcing the Third Dimension. Cell 125, 429–431 (2006).

  83. 83.

    , & Three-dimensional cell culture matrices: state of the art. Tissue Eng. Part B Rev. 14, 61–86 (2008).

  84. 84.

    , , & Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia 12, 453–463 (2010).

  85. 85.

    , & Detection of hydroxyapatite in calcified cardiovascular tissues. Atheroscler. 224, 3340–3347 (2012).

  86. 86.

    , , & Stable magnetic field gradient levitation of Xenopus laevis: toward low gravity simulation. Biophys. J. 73, 1130–1133 (1997).

  87. 87.

    & Low gravity on earth by magnetic levitation of biological material. J. Gravit. Physiol. 9, 7–10 (2002).

  88. 88.

    et al. Diamagnetic levitation changes growth, cell cycle, and gene expression of Saccharomyces cerevisiae. Biotechnol. Bioeng. 98, 854–863 (2007).

  89. 89.

    , , & Magnetic levitation-based Martian and Lunar gravity simulator. Adv. Space Res. 36, 114–118 (2005).

  90. 90.

    , & Adipose tissue engineering in three-dimensional levitation culture system based on magnetic nanoparticles. Tiss. Engr. Part C Meth. 19, 336–344 (2013).

  91. 91.

    et al. Assembly of a three-dimensional multitype bronchiole co-culture model using magnetic levitation. Tiss. Eng. Part C Methods 25 Feb 2013 (doi:10.1089/ten.TEC.2012.0157).

  92. 92.

    , & The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. J. Transl. Med. 10, 38 (2012).

  93. 93.

    , , & Magnetic levitation of MC3T3 osteoblast cells as a ground based simulation of microgravity. Micrograv. Sci. Technol. 21, 311–318 (2009).

  94. 94.

    et al. Large gradient high magnetic field affects the association of MACF-1 with actin and microtubule cytoskeleton. Bioelectromag. 30, 545–555 (2009).

  95. 95.

    , , , & Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner. Am. J. Physiol. Cell Physiol. 291, C668–C677 (2006).

  96. 96.

    , , & Shear stress induces internalization of E-cadherin and invasiveness in metastatic oesophageal cancer cells by a Src-dependent pathway. Cancer Sci. 100, 1082–1087 (2009).

  97. 97.

    , , , & Effects of tumor-leukocyte environment on melanoma – neutrophil adhesion to the endothelium in a shear flow. Cell. Mol. Bioeng. 1, 189–200 (2008).

  98. 98.

    , , & What does physics have to do with cancer? Nature Rev. Cancer 11, 657–670 (2011).

  99. 99.

    , & The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nature Rev. Cancer 11, 512–522 (2011). This paper reviews key elements of the effect of physical forces on cancer cell metastasis in the context of a 3D configuration.

  100. 100.

    et al. Overcoming evasive resistance from vascular endothelial growth factor A inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducing factor 1 alpha. Int. J. Cancer 132, 29–41 (2013).

  101. 101.

    et al. Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PLoS ONE 4, e5947 (2009).

  102. 102.

    , & Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int. J. Biochem. 3, 117–136 (2012).

  103. 103.

    et al. Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells. Br. J. Cancer 101, 1290–1297 (2009).

  104. 104.

    et al. Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer. BMC Cancer 13 Jan 2012 (doi:10.1186/1471-2407).

  105. 105.

    et al. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. Natl Acad. Sci. USA 90, 3294–3298 (1993).

  106. 106.

    et al. Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J. Natl Cancer Inst. 86, 975–982 (1994).

  107. 107.

    , , & Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Hum. Cell 9, 257–264 (1996).

  108. 108.

    & Multicellular resistance: a paradigm for clinical resistance? Crit. Rev. Oncol. Hematol. 36, 193–207 (2000).

  109. 109.

    et al. Spaceflight alters immune cell function and distribution. J. Appl. Physiol. 73, 191S–195S (1992).

  110. 110.

    et al. Immune changes in test animals during spaceflight. J. Leuk. Biol. 54, 214–226 (1993).

  111. 111.

    et al. Spaceflight and development of immune responses. J. Appl. Physiol. 85, 1429–1433 (1998).

  112. 112.

    , , & Changes in the immune system during and after spaceflight. Adv. Space Biol. Med. 6, 1–32 (1997).

  113. 113.

    et al. Spaceflight effects on T lymphocyte distribution, function and gene expression. J. Appl. Physiol. 106, 194–202 (2009). This paper presents microgravity-induced effects on T cells, as well as on the expression of cancer-associated genes, and also reviews earlier studies on the effects of reduced gravity exposure on the immune system.

  114. 114.

    , , , & Cytokine secretion by immune cells in space. J. Leuk. Biol. 52, 104–110 (1992).

  115. 115.

    , & Influence of spaceflight on the production of interleukin-3 and interleukin-6 by rat spleen and thymus cells. J. Appl. Physiol. 78, 810–813 (1995).

  116. 116.

    & Mortality among US astronauts: 1980–2009. Aviat. Space Environ. Med. 81, 1024–1027 (2010).

  117. 117.

    , & (eds) in Review of NASA's Longitudinal Study of Astronaut Health 24–25 (Institute of Medicine of the National Academies, 2004).

  118. 118.

    et al. Gene expression in space. Nature Med. 5, 359 (1999).

  119. 119.

    et al. Mechanical culture conditions affect gene expression: gravity-induced changes on the space shuttle. Physiol. Genom. 8, 163–173 (2000). This paper details the first demonstration of microgravity exposure to elicit broad modulation of cellular gene expression.

  120. 120.

    et al. cDNA microarray reveals altered cytoskeletal expression in space-flown leukemic T lymphocytes (Jurkat). FASEB J. 15, 1783–1805 (2001). This paper details the first demonstration of microgravity-induced alterations of global gene expression in Jurkat cells and provides insight into potential mechanisms underlying cellular cytoskeletal disruption occurring in space.

  121. 121.

    et al. Spaceflight alters microtubules and increases apoptosis in human lymphocytes (Jurkat). FASEB J. 12, 1007–1018 (1998).

  122. 122.

    et al. Spaceflight alters the gene expression profile of cervical cancer cells. Chin. J. Cancer 30, 842–852 (2011).

  123. 123.

    et al. Identification of genes associated with tumor development in CaSki cells in the cosmic space. Mol. Biol. Rep. 39, 6923–6931 (2012).

  124. 124.

    et al. Plectin-1 as a novel biomarker for pancreatic cancer. Clin. Cancer Res. 17, 302–309 (2010).

  125. 125.

    , & Plectin sidearms mediate interactions of intermediate filaments with microtubules and other components of the cytoskeleton. J. Cell Biol. 135, 991–1007 (1996).

  126. 126.

    et al. Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma. J. Proteom. 75, 1803–1815 (2012).

  127. 127.

    & Plectin regulates invasiveness of SW480 colon carcinoma cells and is targeted to podosome-like adhesions in an isoform-specific manner. Exp. Cell Res. 317, 2468–2478 (2011).

  128. 128.

    et al. The distribution of protein kinase C in human leukocytes is altered in microgravity. FASEB J. 10, 1627–1634 (1996).

  129. 129.

    et al. The kinetics of translocation and cellular quantity of protein kinase C in human leukocytes are modified during spaceflight. FASEB J. 13, S23–S33 (1999).

  130. 130.

    , , & Microgravity modifies protein kinase C isoform translocation in the human monocytic cell line U937 and human peripheral blood T cells. J. Cell. Biochem. 87, 39–50 (2002).

  131. 131.

    , & Microgravity reduces the differentiation of human osteoblastic MG-63 cells. J. Bone Min. Res. 12, 786–794 (1997).

  132. 132.

    , , & Prolonged weightlessness affects promyelocytic multidrug resistance. Exp. Cell Res. 237, 410–418 (1997).

  133. 133.

    . et al. The effect of weightlessness on cytoskeletal architecture and proliferation of human breast cancer cell line MCF-7. FASEB J. 15, 1104–1106 (2001).

  134. 134.

    et al. Characterization of the tumorigenic and metastatic potential of a poorly differentiated human colon carcinoma cell line. Invasion Met. 10, 253–266 (1990).

  135. 135.

    et al. Antigenic protein in microgravity-grown human mixed mullerian ovarian tumor (LN1) cells preserved in RNA stabilizing agent. Grav. Space Biol. 18, 99–100 (2005).

  136. 136.

    et al. Regulatory effect of E2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells. Cell. Mol. Immunol. 2, 365–372 (2005).

  137. 137.

    , , , & Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8 and monocyte chemotactic protein 1 in the paclitaxel resistant phenotype. Clin. Cancer Res. 5, 3445–3553 (1999).

  138. 138.

    et al. Reciprocal regulation of 5 alpha-dihydrotesterone, interleukin-6 and interleukin-8 during proliferation of epithelial ovarian carcinoma. Cancer Biol. Therap. 6, 864–871 (2007).

  139. 139.

    , , , & The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma. Oncol. Rep. 29, 34–38 (2013).

  140. 140.

    et al. Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanid for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials. Lancet Oncol. 13, 827–837 (2012).

  141. 141.

    et al. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8. Breast Cancer Res. Treat. 135, 737–747 (2012).

  142. 142.

    , & Cytogenetic, morphologic and oncogene analysis of cell line derived from heterologous mixed mullerian tumor of the ovary. In Vitro Cell. Dev. Biol. Anim. 33, 325–331 (1997).

  143. 143.

    Prostate modeling experiment success becomes part of legacy of shuttle astronauts. J. Natl Cancer Inst. 95, 505–507 (2003).

  144. 144.

    , , & Matricellular proteins: a sticky affair with cancers. J. Oncol. 9 Feb 2012 (doi:10.1155/2012/351089).

  145. 145.

    , , & Advances in tenascin-c biology. Cell. Mol. Life Sci. 68, 3175–3199 (2011).

  146. 146.

    The cytoskeleton in spaceflown cells: an overview. Grav. Space Biol. Bull. 17, 1–11 (2004). This paper reviews key concepts and mechanisms regarding cell shape changes and associated cytoskeletal alterations induced by microgravity exposure.

  147. 147.

    Gravity dependence of microtubule self-organization. Grav. Space Biol. Bull. 17, 13–25 (2004). This paper describes the influence of spatial configuration and gravity on microtubule reaction-diffusion processes.

  148. 148.

    , & Microtubule self-organization is gravity-dependent. Proc. Natl Acad. Sci. USA 97, 8364–8368 (2000).

  149. 149.

    , & Ground-based methods reproduce space-flight experiments and show that weak vibrations trigger microtubule self-organisation. Biophys. Biochem. 121, 1–6 (2006).

  150. 150.

    et al. Integrity of actin fibers and microtubules influences metastatic tumor adhesion. Exp. Cell Res. 299, 236–247 (2004).

  151. 151.

    Biomechanics and biophysics of cancer cells. Acta Biomater. 3, 413–438 (2007).

  152. 152.

    , & The role of microenvironment in tumor growth and invasion. Prog. Biophys. Mol. Biol. 106, 353–379 (2011).

  153. 153.

    & Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension. Biophys. J. 66, 2181–2189 (1994).

  154. 154.

    From cellular mechanotransduction to biologically inspired engineering. Ann. Biomed. Eng. 38, 1148–1161 (2010).

  155. 155.

    et al. Mechanical behavior in living cells consistent with the tensegrity model. Proc. Natl Acad. Sci. USA 98, 7765–7770 (2001). This paper details cellular structure and biomechanics as governed by the principles of tensegrity.

  156. 156.

    , & Demonstration of mechanical connections between integrins, cytoskeletal filaments and nucleoplasm that stabilize nuclear structure. Proc. Natl Acad. Sci. USA 94, 849–854 (1997).

  157. 157.

    Tensegrity I. Cell structure and hierarchical systems biology. J. Cell Sci. 116, 1157–1173 (2003).

  158. 158.

    How cells (might) sense microgravity. FASEB J. 13, S3–S15 (1999). This paper reviews how cells may perceive, and respond mechanically, to alterations in gravity.

  159. 159.

    et al. Implications for interrelationships between nuclear architecture and control of gene expression under microgravity conditions. FASEB J. 13, S157–S166 (1999).

  160. 160.

    et al. Cell cycling determines integrin-mediated adhesion in osteoblastic ROS 17\\2.8 cells exposed to space-related conditions. FASEB J. 15, 2036–2038 (2001).

  161. 161.

    et al. Cell stiffness if a biomarker of the metastatic potential of ovarian cancer cells. PLoS ONE 7, e46609 (2012).

  162. 162.

    et al. Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophy. J. 88, 3689–3698 (2005).

  163. 163.

    Overview of the spaceflight radiation environment and its impact on cell biology experiments. J. Gravit. Space Phys. 11, 11–16 (2004).

  164. 164.

    Does reduced gravity alter cellular response to ionizing radiation? Radiat. Environ. Biophys. 45, 1–8 (2006).

  165. 165.

    Once we know all the radiobiology we need to know, how can we use it to predict space radiation risks and achieve fame and fortune? Phys. Med. 17, 5–12 (2001).

  166. 166.

    et al. Multiplexed profiling of secreted proteins for the detection of potential space biomarkers. Mol. Med. Rep. 4, 17–23 (2011).

  167. 167.

    Biomarkers of space radiation risk. Radiat. Res. 164, 467–473 (2005).

  168. 168.

    et al. Thyroid cell growth: sphingomyelin metabolism as non-invasive marker for cell damage acquired during spaceflight. Astrobiol. 10, 811–820 (2010).

  169. 169.

    & Proteomics and genomics of microgravity. Physiol. Genom. 26, 163–171 (2006).

  170. 170.

    , , , & How and why does the proteome respond to gravity? Expert Rev. Proteom. 8, 13–27 (2011).

  171. 171.

    , , & Cancer research: past, present and future. Nature Rev. Cancer 11, 749–754 (2011).

  172. 172.

    Canadian Space Agency. Cancer treatment delivery. International Space Station Benefits for Humanity [], (2012).

  173. 173.

    et al. Ultrasound guided combined cryoablation and microencapsulated 5-fluorouracil inhibits growth of human prostate tumors in xenogenic mouse model assessed by luminescence imaging. Technol. Cancer Res.Treat. 3, 135–142 (2004).

  174. 174.

    et al. Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer. Technol. Cancer Res. Treat. 8, 207–216 (2009).

  175. 175.

    , , & Potato tuber formation in the spaceflight environment. Life Support Biosph. Sci. 4, 71–76 (1997).

  176. 176.

    , , , & Ground-based studies and space experiment with potato leaf explants. Life Support Biosph. Sci. 6, 97–106 (1999).

  177. 177.

    et al. Effect of NASA light-emitting diode irradiation on molecular changes for wound healing diabetic mice. J. Clin. Laser Med. Surg. 21, 67–74 (2003).

  178. 178.

    et al. Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients. Support Care Cancer 20, 1405–1415 (2012).

  179. 179.

    , , , & Low-level laser therapy in acute pain: a systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. Photomed. Laser Surg. 24, 158–168 (2006).

  180. 180.

    et al. COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low level laser therapy. Inflamm. Res. 56, 228–229 (2007).

  181. 181.

    et al. Toward optimizing lighting as a countermeasure to sleep and circadian disruption in space flight. Acta Astronaut. 56, 1017–1024 (2005).

  182. 182.

    et al. Sensitivity of the human circadian system to short-wavelength (420 nm) light. J. Biol. Rhythms 23, 379–386 (2008).

  183. 183.

    et al. Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J. Appl. Physiol. 110, 619–626 (2011).

  184. 184.

    , , & Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Integr. Cancer Therap. 8, 347–353 (2009).

  185. 185.

    , & Ocular input for human melatonin regulation: relevance to breast cancer. Neuro. Endocrinol. Lett. 23, 17–22 (2002).

  186. 186.

    et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 65, 11174–11184 (2005).

  187. 187.

    et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Natl Cancer Inst. 93, 1563–1568 (2001).

  188. 188.

    et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J. Natl Cancer Inst. 95, 825–828 (2003).

Download references

Acknowledgements

The authors dedicate this article in memory of Neil Alden Armstrong, with grateful appreciation and respect for his dedication and commitment to the exploration of space.

Author information

Affiliations

  1. Nano3D Biosciences, 7,000 Fannin Street, Suite 2140, Houston TX 77030, USA.

    • Jeanne L. Becker
    •  & Glauco R. Souza

Authors

  1. Search for Jeanne L. Becker in:

  2. Search for Glauco R. Souza in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Jeanne L. Becker.

Glossary

Nuclear force

The force holding together subatomic particles of the nucleus.

Electromagnetic force

The force associated with electric and magnetic fields.

Microgravity

Conditions of reduced gravity experienced specifically in the space environment.

Standard gravity

The natural force of attraction exerted by Earth on objects at or near its surface.

Low Earth orbit

A circular orbit extending to approximately 1,200 miles above the Earth's surface.

Gravity-dependent convection

Movement of fluid or gas affected by gravity.

Hydrodynamic shear

Stress arising in a fluid that is a function of the fluid velocity gradient and viscosity.

Sedimentation

The settling of solid material from a state of suspension.

Discoid

Disc-like shape of normal red blood cells.

Echinocytic

Abnormally shaped red blood cells exhibiting blunt spicule protrusions.

Spheroids

Three-dimensional multicellular clusters or aggregates.

Turbulence

Disordered motion in a fluid yielding disrupted and irregular flow.

Laminar flow

Fluid flow occurring in layers.

Clinostat

A horizontally rotating culture device.

Clinorotation

Rotation of a culture vessel about its horizontal axis.

Membrane oxygenation

Oxygen delivered to cells in a culture vessel via a gas-permeable membrane.

Gravitational vector

Unidirectional downward pull of the force of gravity.

Warm bore superconductive magnet

A strong field (100 T per m gradient) magnet, similar to a high-field nuclear magnetic resonance spectroscopic magnet.

Histogenesis

Growth and differentiation of cells to form specialized tissue.

Tensegrity

Also known as tensional integrity. A biomechanical principle of continuous tension or prestress that imparts stability and integrity in a spatial system and that facilitates responsiveness to environmental cues.

Prestress

Resting tension that provides structural integrity.

Oral mucositis

Inflammation and ulceration occurring in the mouth, often experienced as a side effect of receiving cancer chemotherapy.

Myeloablative treatment

The use of antitumour therapy to eliminate cancer in the bone marrow.

Light therapy

Administration of varying wavelengths of light to affect a biological outcome.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrc3507

Further reading